Uncover key drivers, emerging technologies, and competitive movements shaping the gastrointestinal pathogen testing market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Gastrointestinal Pathogen Testing Market in 2026, and what figure is it projected to hit by 2030?
The gastrointestinal pathogen testing market size has shown consistent growth in recent years. This market is expected to increase from $4.23 billion in 2025 to $4.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. Historically, this expansion has been influenced by the high incidence of gastrointestinal infections, the widespread adoption of culture-based testing, the enlargement of hospital laboratories, occurrences of foodborne illness outbreaks, and the establishment of public health surveillance programs.
The gastrointestinal pathogen testing market size is anticipated to show stable development over the coming period. This market is set to reach $5.06 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 3.5%. The expansion during this forecast timeframe is primarily driven by an increase in syndromic testing panels, the broadening of point-of-care diagnostics, the need for faster turnaround times, the incorporation of molecular diagnostics, and heightened awareness of infectious diseases. Prominent trends within the forecast period encompass the increasing application of multiplex molecular diagnostic panels, a greater need for rapid stool testing, the broadening of point-of-care GI diagnostics, the increasing acceptance of PCR-based testing, and a stronger emphasis on infection surveillance.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp
Which Drivers Are Affecting Market Participation In The Gastrointestinal Pathogen Testing Market?
The increasing occurrence of foodborne illnesses is projected to stimulate growth within the gastrointestinal pathogen testing market. These illnesses arise from consuming food or drinks contaminated with harmful microorganisms, toxins, or chemicals, encompassing conditions like listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The escalation in foodborne incidents stems from various factors, including evolving patterns in food production, distribution, and consumption, insufficient food safety protocols, and the impact of climate change on food supply. Gastrointestinal testing plays a crucial role by identifying specific pathogens responsible for these illnesses, enabling healthcare providers to pinpoint the cause of symptoms, prescribe suitable treatment, track outbreaks, and implement preventative measures to curb the spread of foodborne diseases. For example, in September 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported that during 2023, the CDC, in collaboration with state and regulatory public health partners, investigated 181 potential multistate outbreaks, with 84 confirmed as actual outbreaks. Outbreak investigators resolved 50 of these outbreaks (60%), identifying a suspected source for 22 and a confirmed source for 28. Consequently, the rising instances of foodborne diseases are propelling the expansion of the gastrointestinal pathogen testing market. The growing challenge of antimicrobial resistance is anticipated to propel the expansion of the gastrointestinal pathogen testing market. Antimicrobial resistance describes the capability of microorganisms such as bacteria and viruses to resist the effects of medications previously effective against them. The demand for gastrointestinal pathogen testing is escalating due to the increasing prevalence of drug-resistant gastrointestinal infections, which necessitate prompt and accurate detection to guide effective treatment and prevent further dissemination. For instance, in October 2025, the World Health Organization, a Switzerland-based specialized agency of the United Nations, stated that it provided a global analysis of antibiotic resistance prevalence and trends, utilizing data from over 23 million bacteriologically confirmed cases of bloodstream infections, urinary tract infections, gastrointestinal infections, and urogenital gonorrhea. Data for this analysis were submitted by 104 countries in 2023. Thus, the escalating antimicrobial resistance is expected to stimulate the gastrointestinal pathogen testing market.
What Segment Classifications Make Up The Gastrointestinal Pathogen Testing Market?
The gastrointestinal pathogen testing market covered in this report is segmented –
1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users
Subsegments:
1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens
2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens
3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens
What Trends Are Driving The Growth Trajectory Of The Gastrointestinal Pathogen Testing Market?
Major companies operating in the gastrointestinal pathogen testing market are concentrating on developing advanced solutions, such as metagenomic diagnostic tests, to enhance the accuracy, speed, and comprehensiveness of detecting gastrointestinal pathogens. A metagenomic diagnostic test represents an advanced technology utilized to analyze the genetic material of microorganisms present in a sample, such as stool or blood. For instance, in April 2024, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel, a metagenomic diagnostic test engineered to identify a wide array of gastrointestinal pathogens with unparalleled accuracy. MetaPanel encompasses 175 pathogen targets in a single test, providing healthcare professionals a comprehensive tool for diagnosing both common and hard-to-detect infections. It employs next-generation sequencing (NGS) technology to examine a broad range of genetic material within a stool sample. This enables the detection of a diverse variety of potential pathogens, including those not routinely tested for in traditional GI (gastrointestinal) panels.
Which Leading Companies Dominate The Gastrointestinal Pathogen Testing Market Share?
Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Gastrointestinal Pathogen Testing Market?
North America was the largest region in the gastrointestinal pathogen testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Gastrointestinal Pathogen Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15571&type=smp
Browse Through More Reports Similar to the Global Gastrointestinal Pathogen Testing Market 2026, By The Business Research Company
Food Pathogen Safety Testing Equipment And Supplies Market Report 2026
Food Pathogen Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/food-pathogen-testing-global-market-report
Infectious Disease Diagnostics Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model